UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 310

Sortiert nach

Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes

JAMA : the journal of the American Medical Association, 2016-10, Vol.316 (13), p.1407

2016

Volltextzugriff (PDF)

Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia

The New England journal of medicine, 2013-07, Vol.369 (3), p.224-232

2013

Volltextzugriff (PDF)

979-P: Glycemic Improvements in CGM-Naïve Patients during SMBG and Implantable CGM Use

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

Retrospective Analysis of 3-Month Real-World Glucose Data After the MiniMed 670G System Commercial Launch

Diabetes technology & therapeutics, 2018-10, Vol.20 (10), p.689

2018

Volltextzugriff (PDF)

Metabolic Complications of Childhood Obesity: Identifying and mitigating the risk

Diabetes care, 2008-02, Vol.31 (2), p.S310-S316

2008

Volltextzugriff (PDF)

Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes

Diabetes technology & therapeutics, 2017-03, Vol.19 (3), p.155

2017

Volltextzugriff (PDF)

Characteristics of Adolescents and Youth with Recent-Onset Type 2 Diabetes: The TODAY Cohort at Baseline

The journal of clinical endocrinology and metabolism, 2011-01, Vol.96 (1), p.159-167

2011

Volltextzugriff (PDF)

Prevention and Treatment of Pediatric Obesity: An Endocrine Society Clinical Practice Guideline Based on Expert Opinion

The journal of clinical endocrinology and metabolism, 2008-12, Vol.93 (12), p.4576-4599

2008

Volltextzugriff (PDF)

Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes

Diabetes technology & therapeutics, 2019-01, Vol.21 (1), p.11

2019

Volltextzugriff (PDF)

Real-World Data from the First U.S. Commercial Users of an Implantable Continuous Glucose Sensor

Diabetes technology & therapeutics, 2019-12, Vol.21 (12), p.677

2019

Volltextzugriff (PDF)

Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial

The lancet. Diabetes & endocrinology, 2019-06, Vol.7 (6), p.462-472

2019

Volltextzugriff (PDF)

Effectiveness of Automated Insulin Management Features of the MiniMed ® 640G Sensor-Augmented Insulin Pump

Diabetes technology & therapeutics, 2016-10, Vol.18 (10), p.657

2016

Volltextzugriff (PDF)

Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study

Diabetes technology & therapeutics, 2022-02, Vol.24 (2), p.84

2022

Volltextzugriff (PDF)

655-P: Evaluation of Accuracy and Longevity of an Implantable CGM System through 365 Days

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

656-P: Effect of Calibration Frequency on Accuracy of a 180-Day Implantable CGM System

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

Device profile of the eversense continuous glucose monitoring system for glycemic control in type-1 diabetes: overview of its safety and efficacy

Expert review of medical devices, 2021-10, Vol.18 (10), p.909-914

2021

Volltextzugriff (PDF)

Influence of Race, Ethnicity, and Culture on Childhood Obesity: Implications for Prevention and Treatment: A consensus statement of Shaping America's Health and the Obesity Society

Diabetes care, 2008-11, Vol.31 (11), p.2211-2221

2008

Volltextzugriff (PDF)

356-OR: Accuracy Evaluation of an Implantable CGM with Chemistry Improvements in a 365-Day Feasibility Study

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

Accuracy of a Fourth-Generation Subcutaneous Continuous Glucose Sensor

Diabetes technology & therapeutics, 2017-08, Vol.19 (8), p.446

2017

Volltextzugriff (PDF)

Evaluation of a Predictive Low-Glucose Management System In-Clinic

Diabetes technology & therapeutics, 2017-05, Vol.19 (5), p.288

2017

Volltextzugriff (PDF)

4-LB: Remission of Type 2 Diabetes and Improvement in Metabolic Markers with the Twin Precision Treatment Technology (TPT) —A Multicenter, Randomized, Controlled Trial

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

691-P: Evaluation of an Implantable CGM System Using a Multiple-Analyte Indicator Hydrogel for Calibration Reduction

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

Impact of Reducing Glycated Hemoglobin on Healthcare Costs Among a Population with Uncontrolled Diabetes

Applied health economics and health policy, 2018-10, Vol.16 (5), p.675-684

2018

Volltextzugriff (PDF)

The metabolic syndrome in children and adolescents - an IDF consensus report

Pediatric diabetes, 2007-10, Vol.8 (5), p.299-306

2007

Volltextzugriff (PDF)

Longitudinal Analysis of Real-World Performance of an Implantable Continuous Glucose Sensor over Multiple Sensor Insertion and Removal Cycles

Diabetes technology & therapeutics, 2020-05, Vol.22 (5), p.422

2020

Volltextzugriff (PDF)

1 – 25 von 310

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(285)
Mit Volltextzugriff
(243)

Publikationsform

Sprache

Englisch
(309)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

Humans
(195)
Science & Technology
(174)
Life Sciences & Biomedicine
(173)
Child
(128)
Adolescent
(112)
Female
(111)
Male
(105)
Endocrinology & Metabolism
(95)
Diabetes
(82)
Biological And Medical Sciences
(73)
Medical Sciences
(67)
Adult
(60)
Pediatrics
(60)
Child, Preschool
(42)
Diabetes Mellitus, Type 1 - Drug Therapy
(40)
Diabetes Mellitus, Type 1 - Blood
(37)
Endocrinopathies
(36)
Blood Glucose - Analysis
(31)
Glucose
(31)
Insulin Infusion Systems
(31)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes

Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia

979-P: Glycemic Improvements in CGM-Naïve Patients during SMBG and Implantable CGM Use

Retrospective Analysis of 3-Month Real-World Glucose Data After the MiniMed 670G System Commercial Launch

Metabolic Complications of Childhood Obesity: Identifying and mitigating the risk

Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes

Characteristics of Adolescents and Youth with Recent-Onset Type 2 Diabetes: The TODAY Cohort at Baseline

Prevention and Treatment of Pediatric Obesity: An Endocrine Society Clinical Practice Guideline Based on Expert Opinion

Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes

Real-World Data from the First U.S. Commercial Users of an Implantable Continuous Glucose Sensor

Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial

Effectiveness of Automated Insulin Management Features of the MiniMed ® 640G Sensor-Augmented Insulin Pump

Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study

655-P: Evaluation of Accuracy and Longevity of an Implantable CGM System through 365 Days

656-P: Effect of Calibration Frequency on Accuracy of a 180-Day Implantable CGM System

Device profile of the eversense continuous glucose monitoring system for glycemic control in type-1 diabetes: overview of its safety and efficacy

Influence of Race, Ethnicity, and Culture on Childhood Obesity: Implications for Prevention and Treatment: A consensus statement of Shaping America's Health and the Obesity Society

356-OR: Accuracy Evaluation of an Implantable CGM with Chemistry Improvements in a 365-Day Feasibility Study

Accuracy of a Fourth-Generation Subcutaneous Continuous Glucose Sensor

Evaluation of a Predictive Low-Glucose Management System In-Clinic

4-LB: Remission of Type 2 Diabetes and Improvement in Metabolic Markers with the Twin Precision Treatment Technology (TPT) —A Multicenter, Randomized, Controlled Trial

691-P: Evaluation of an Implantable CGM System Using a Multiple-Analyte Indicator Hydrogel for Calibration Reduction

Impact of Reducing Glycated Hemoglobin on Healthcare Costs Among a Population with Uncontrolled Diabetes

The metabolic syndrome in children and adolescents - an IDF consensus report

Longitudinal Analysis of Real-World Performance of an Implantable Continuous Glucose Sensor over Multiple Sensor Insertion and Removal Cycles

Suchergebnisse filtern